Table 1.
Demographic and clinical characteristics of HIV cohort by age category.
| Missing (%) | Overall, N (%) | 40--50 years | 51--60 years | ≥61 years | P | |
| n | 101 | 30 | 35 | 36 | ||
| Age [median (IQR)] | 56 [50--62] | 46 [44--49] | 56 [53--58] | 66 [62--69] | <0.001 | |
| Male | 81 (80.2) | 21 (70.0) | 29 (82.9) | 31 (86.1) | 0.257 | |
| BMI [median (IQR)] | 3 | 26 [23--29] | 27 [25--30] | 25 [21--29] | 25 [21--28] | 0.040 |
| Born in Canada | 50 (49.5) | 12 (40.0) | 19 (54.3) | 19 (52.8) | 0.475 | |
| Race | 0.051 | |||||
| Asian | 10 (9.9) | 4 (13.3) | 5 (14.3) | 1 (2.8) | ||
| Black | 17 (16.8) | 8 (26.7) | 4 (11.4) | 5 (13.9) | ||
| Caucasian | 62 (61.4) | 14 (46.7) | 21 (60.0) | 27 (75.0) | ||
| Hispanic | 5 (5.0) | 3 (10.0) | 0 (0.0) | 2 (5.6) | ||
| Other | 7 (6.9) | 1 (3.3) | 5 (14.3) | 1 (2.8) | ||
| Risk factor | 0.473 | |||||
| MSM only | 74 (73.3) | 18 (60.0) | 27 (77.1) | 29 (80.6) | ||
| IDU only | 1 (1.0) | 1 (3.3) | 0 (0.0) | 0 (0.0) | ||
| MSM and IDU | 2 (2.0) | 1 (3.3) | 1 (2.9) | 0 (0.0) | ||
| Heterosexual contact | 15 (14.9) | 5 (16.7) | 5 (14.3) | 5 (13.9) | ||
| Other/unknown | 9 (8.9) | 5 (16.7) | 2 (5.7) | 2 (5.6) | ||
| Duration of HIV (Y) | 21 [12--28] | 16 [11--19] | 22 [8--29] | 25 [18--29] | 0.001 | |
| CD4+ Nadir [median (IQR)] | 208 [83--306] | 267 [170--368] | 180 [80--320] | 153 [48--266] | 0.047 | |
| Current CD4+ [median (IQR)] | 574 [417--794] | 690 [550--869] | 535 [362--822] | 544 [404--678] | 0.063 | |
| Education | 0.335 | |||||
| Elementary | 6 (5.9) | 1 (3.3) | 2 (5.7) | 3 (8.3) | ||
| Secondary | 35 (34.7) | 7 (23.3) | 17 (48.6) | 11 (30.6) | ||
| Post-secondary | 45 (44.6) | 17 (56.7) | 13 (37.1) | 15 (41.7) | ||
| Masters or PhD | 15 (14.9) | 5 (16.7) | 3 (8.6) | 7 (19.4) | ||
| Income | 1 | 0.142 | ||||
| <$20 000 | 35 (35.0) | 8 (26.7) | 17 (48.6) | 10 (28.6) | ||
| $20 000--$49 999 | 32 (32.0) | 7 (23.3) | 9 (25.7) | 16 (45.7) | ||
| $50 000--$99 999 | 24 (24.0) | 10 (33.3) | 7 (20.0) | 7 (20.0) | ||
| >$100 000 | 9 (9.0) | 5 (16.7) | 2 (5.7) | 2 (5.7) | ||
| Smoking | 0.066 | |||||
| Current | 22 (21.8) | 7 (23.3) | 9 (25.7) | 6 (16.7) | ||
| Past | 40 (39.6) | 6 (20.0) | 16 (45.7) | 18 (50.0) | ||
| Never | 39 (38.6) | 17 (56.7) | 10 (28.6) | 12 (33.3) | ||
| Alcohol use | 0.306 | |||||
| None | 32 (31.7) | 11 (36.7) | 12 (34.3) | 9 (25.0) | ||
| Occasional | 38 (37.6) | 12 (40.0) | 13 (37.1) | 13 (36.1) | ||
| 2–3 per week | 14 (13.9) | 3 (10.0) | 7 (20.0) | 4 (11.1) | ||
| Daily | 11 (10.9) | 1 (3.3) | 2 (5.7) | 8 (22.2) | ||
| Weekends | 6 (5.9) | 3 (10.0) | 1 (2.9) | 2 (5.6) | ||
| Recreational drug use | 0.626 | |||||
| Current | 29 (28.7) | 8 (26.7) | 13 (37.1) | 8 (22.2) | ||
| Past | 30 (29.7) | 10 (33.3) | 10 (28.6) | 10 (27.8) | ||
| Never | 42 (41.6) | 12 (40.0) | 12 (34.3) | 18 (50.0) | ||
| Average daily fiber (g) (IQR) | 18 [11--25] | 17 [7--28] | 16 [11--19] | 20 [15--26] | 0.082 | |
| Average daily fiber ≥20 g (IQR) | 40 (39.6) | 13 (43.3) | 8 (22.9) | 19 (52.8) | 0.032 |
IDU, injection drug use; IQR, interquartile range.